Germany-based online retailer Sunday Natural is reportedly considering options including a potential sale of the business.

The company manufactures nutrition products including vitamins and food supplements.

Citing individuals familiar with the development, Reuters reported that the company is working on a deal with US boutique investment bank Houlihan Lokey.

The news agency further reported that the possible transaction could value the business between €600m ($655m) and €800m ($873m).

The report also noted that private equity and consumer healthcare firms have expressed interest in the auction for Sunday Natural. CVC Partners and others are said to have already submitted initial bids in the past few weeks.

The sources added that the current discussions may or may not result in a deal.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Sunday Natural was launched by a group of dieticians and other nutrition specialists in 2013 and aims to develop products with high-quality, raw ingredients.

The retailer distributes products directly to customers through its website. The Covid-19 pandemic has led to a significant increase in consumer spending on health and wellness products.

The sources added that the company expects earnings before interest, tax, depreciation and amortisation (EBITDA) of approximately €50m ($54m) in the current fiscal, compared to an EBITDA of €30m ($32m) in 2022.

Nestlé reportedly purchased The Bountiful Company’s vitamin and supplements brands in a deal valued at $5.75bn in 2021 from KKR.